Clinical Trials Logo

Post-Surgical Ocular Pain clinical trials

View clinical trials related to Post-Surgical Ocular Pain.

Filter by:
  • None
  • Page 1

NCT ID: NCT04592081 Recruiting - Clinical trials for Post-Surgical Ocular Pain

Dextenza Within Upper Lid Canaliculus Compared With Lower Lid Canaliculus Following Bilateral Cataract Extraction Surgery With PCIOL.

Start date: August 1, 2020
Phase: Phase 4
Study type: Interventional

Assessing DEXTENZA efficacy when placed within the upper eyelid canaliculus as opposed to the lower eyelid canaliculus.

NCT ID: NCT04324359 Completed - Clinical trials for Post-surgical Ocular Pain

Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects

Start date: March 3, 2020
Phase: Phase 2
Study type: Interventional

SURF-201 is being studied for the treatment of eye inflammation and pain in people who are undergoing cataract surgery. SURF-201 is an investigational drug (which means the study drug is currently being tested) in the form of a sterile eye drop. The purpose of this research study is to see how well SURF-201 works and what side effects there are, and to compare it with Vehicle (placebo). This study will involve about 80 study participants at several different research sites in the United States.

NCT ID: NCT02736175 Completed - Clinical trials for Post-Surgical Ocular Pain

OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery

Start date: October 2015
Phase: Phase 3
Study type: Interventional

The objective of the study was to evaluate the safety and efficacy of OTX-DP (dexamethasone insert) 0.4 mg for intracanalicular use when placed in the canaliculus of the eyelid for the treatment of post-surgical inflammation and pain in subjects who had undergone cataract extraction with intraocular lens implantation

NCT ID: NCT02089113 Completed - Clinical trials for Post-Surgical Ocular Pain

OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery

Start date: April 2014
Phase: Phase 3
Study type: Interventional

The objective of the study was to evaluate the safety and efficacy of OTX-DP (dexamethasone insert) 0.4 mg for intracanalicular use when placed in the canaliculus of the eyelid for the treatment of post-surgical inflammation and pain in subjects who had undergone cataract extraction with intraocular lens implantation